Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Risankizumab eases symptoms in nonpustular palmoplantar psoriasis
In patients with nonpustular palmoplantar psoriasis (nPPP), treatment with risankizumab relieves disease symptoms, such as skin pain in palms or soles of feet, by week 16, as shown by the results of a post hoc analysis of the phase IIIb IMMprint study. These improvements persist up to week 52.
Risankizumab eases symptoms in nonpustular palmoplantar psoriasis
12 Oct 2024
Long-term secukinumab safe, effective in kids with plaque psoriasis
Long-term treatment with secukinumab, either at low or high dose, results in sustained efficacy and better health-related quality of life up to 4 years in children and adolescents with moderate-to-severe chronic plaque psoriasis, as shown in a phase III study presented at EADV 2024.
Long-term secukinumab safe, effective in kids with plaque psoriasis
11 Oct 2024
Clozapine-treated patients with schizophrenia at risk for ileus, pneumonia
Ileus and pneumonia occur more frequently than previously reported among individuals with schizophrenia treated with clozapine, reveals a recent study, noting that such conditions also contribute to increased mortality.
Clozapine-treated patients with schizophrenia at risk for ileus, pneumonia
10 Oct 2024
Hormone therapy prevents relapse in women with schizophrenia
The use of menopausal hormone therapy (MHT) can provide protection against psychosis relapse among women of menopausal age with schizophrenia or schizoaffective disorder (SSD), a study has shown.